Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Arginine in Preventing Cancers. A Single Center, Open, Prospective Study

NCT03940053 is registered in ClinicalTrials.gov with Zujiang YU as lead sponsor.

NCT NCT03940053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03940053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Arginine in Preventing Cancers. A Single Center, Open, Prospective Study
Lead sponsor
Zujiang YU
Phase
Phase 3
Overall status
Unknown status
Start date
May 10, 2019
Completion date
May 10, 2025
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer